Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Valdes-Mora

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Epigenomics|November 29, 2013
Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancerAndrew Stone, Fatima Valdes-Mora, Susan J Clark
Epigenomics|April 19, 2016
H2A.Z acetylation and transcription: ready, steady, go!Yolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
Trends in Genetics : TIG|March 2, 2022
The H2A.Z-nucleosome code in mammals: emerging functionsYolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
International Journal of Molecular Sciences|August 14, 2025
Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and ImplicationsDana Kisswani, Christina Carroll, Fatima Valdes-Mora, et al.
Trends in Genetics : TIG|October 27, 2021
The H2A.Z-nuclesome code in mammals: emerging functionsYolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
Cells|March 4, 2020
Myeloid-Derived Suppressor Cells as a Therapeutic Target for CancerAndrew M K Law, Fatima Valdes-Mora, David Gallego-Ortega
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2020
Genomic Cytometry and New Modalities for Deep Single-Cell InterrogationRobert Salomon, Luciano Martelotto, Fatima Valdes-Mora, et al.
Trends in Cancer|September 29, 2024
EZHIP's role in diffuse midline glioma: echoes of oncohistones?Afraah Cassim, Matthew D Dun, David Gallego-Ortega, et al.
Frontiers in Cell and Developmental Biology|June 9, 2023
Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologiesÂngela Sousa, Christiane P Soares, Chung Man Chin, et al.
STAR Protocols|September 29, 2021
Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancerLaura Rodriguez de la Fuente, Andrew M K Law, David Gallego-Ortega, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Epigenomics|November 29, 2013
Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancerAndrew Stone, Fatima Valdes-Mora, Susan J Clark
Epigenomics|April 19, 2016
H2A.Z acetylation and transcription: ready, steady, go!Yolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
Trends in Genetics : TIG|March 2, 2022
The H2A.Z-nucleosome code in mammals: emerging functionsYolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
International Journal of Molecular Sciences|August 14, 2025
Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and ImplicationsDana Kisswani, Christina Carroll, Fatima Valdes-Mora, et al.
Trends in Genetics : TIG|October 27, 2021
The H2A.Z-nuclesome code in mammals: emerging functionsYolanda Colino-Sanguino, Susan J Clark, Fatima Valdes-Mora
Cells|March 4, 2020
Myeloid-Derived Suppressor Cells as a Therapeutic Target for CancerAndrew M K Law, Fatima Valdes-Mora, David Gallego-Ortega
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2020
Genomic Cytometry and New Modalities for Deep Single-Cell InterrogationRobert Salomon, Luciano Martelotto, Fatima Valdes-Mora, et al.
Trends in Cancer|September 29, 2024
EZHIP's role in diffuse midline glioma: echoes of oncohistones?Afraah Cassim, Matthew D Dun, David Gallego-Ortega, et al.
Frontiers in Cell and Developmental Biology|June 9, 2023
Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologiesÂngela Sousa, Christiane P Soares, Chung Man Chin, et al.
STAR Protocols|September 29, 2021
Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancerLaura Rodriguez de la Fuente, Andrew M K Law, David Gallego-Ortega, et al.
Pageof 4